Gut Microbiome Intervention With EXL01 in Combination With Nivolumab and FOLFOX as First-line Treatment for Patients With PD-L1 CPS ≥5 Metastatic Gastric Cancer: A Randomized GERCOR Phase II Study (BIG)
Latest Information Update: 24 Jun 2025
At a glance
Most Recent Events
- 17 Jun 2025 Planned End Date changed from 1 Mar 2029 to 1 Dec 2029.
- 17 Jun 2025 Planned primary completion date changed from 1 Mar 2026 to 1 Apr 2027.
- 25 Jul 2024 Status changed from not yet recruiting to recruiting.